Patients with hypersensitivity to any component of Arcoxia; congestive heart failure (NYHA II-IV); established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease [including patients who have recently undergone coronary artery bypass graft (CABG) surgery or angioplasty].
Daftar Gratis untuk melanjutkan membaca
Sumber terlengkap se-Asia untuk informasi medis, referensi klinis, dan pendidikan
Sign Out
